Codes / ICD10CM / T43.215A

T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter

Summary

This condition refers to an unwanted reaction to selective serotonin and norepinephrine reuptake inhibitors (SSNRIs), a class of antidepressant medications, occurring during the initial phase of exposure. It is identified by clinical presentation, medication history, and the nature of the reaction.

Causes

The adverse effects are caused by the body's reaction to or inability to tolerate SSNRIs, leading to undesired symptoms that arise when starting or adjusting the medication.

Risk Factors

  • First-time use of SSNRIs
  • Rapid dose escalation
  • Pre-existing health conditions such as liver or kidney disease
  • Concurrent use of other medications that may interact with SSNRIs

Symptoms

  • Nausea, vomiting, or abdominal pain
  • Dizziness, drowsiness, or confusion
  • Rapid heart rate or changes in blood pressure
  • Tremors or muscle twitching
  • Sleep disturbances
  • Mood changes

Diagnosis

Diagnosis is based on a thorough patient history, including medication use and timing of symptom onset, along with clinical assessment of symptoms. Laboratory tests may be used to rule out other causes.

Treatment Options

  • Adjusting the SSNRI dose or switching to an alternative medication
  • Symptomatic treatment (e.g., antiemetics for nausea)
  • Supportive care for symptom management
  • Monitoring for severe reactions requiring intervention

Prognosis and Follow-Up

Symptoms often resolve with dose adjustment or discontinuation of the medication. Regular follow-up is recommended to assess response and adjust treatment as needed.

Complications

  • Severe allergic reactions (e.g., anaphylaxis)
  • Serotonin syndrome (in rare cases)
  • Worsening of underlying mental health conditions

Lifestyle & Prevention

  • Start SSNRIs at a low dose and increase gradually under medical supervision
  • Avoid abrupt discontinuation of the medication
  • Report any new or worsening symptoms to a healthcare provider promptly

When to Seek Professional Help

Seek immediate medical attention if symptoms are severe (e.g., difficulty breathing, seizures) or if there are signs of an allergic reaction (e.g., rash, swelling).

Tips for Medical Coders

Document the specific SSNRI involved, the timing of symptom onset relative to medication initiation, and any interventions performed. Ensure the encounter is coded as "initial" if this is the first presentation of the adverse effect.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T43.215A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.